MXPA03003576A - Procedimiento para plegar polipeptidos sintetizados quimicamente. - Google Patents

Procedimiento para plegar polipeptidos sintetizados quimicamente.

Info

Publication number
MXPA03003576A
MXPA03003576A MXPA03003576A MXPA03003576A MXPA03003576A MX PA03003576 A MXPA03003576 A MX PA03003576A MX PA03003576 A MXPA03003576 A MX PA03003576A MX PA03003576 A MXPA03003576 A MX PA03003576A MX PA03003576 A MXPA03003576 A MX PA03003576A
Authority
MX
Mexico
Prior art keywords
chemically synthesized
folding
synthesized polypeptides
cysteine
reducing agent
Prior art date
Application number
MXPA03003576A
Other languages
English (en)
Inventor
Antonio Verdini
Original Assignee
Rmf Dictagene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rmf Dictagene Sa filed Critical Rmf Dictagene Sa
Publication of MXPA03003576A publication Critical patent/MXPA03003576A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MXPA03003576A 2000-11-27 2001-11-27 Procedimiento para plegar polipeptidos sintetizados quimicamente. MXPA03003576A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00204207 2000-11-27
PCT/EP2001/014163 WO2002050099A2 (en) 2000-11-27 2001-11-27 Process for folding chemically synthesized polypeptides

Publications (1)

Publication Number Publication Date
MXPA03003576A true MXPA03003576A (es) 2003-10-14

Family

ID=8172340

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03003576A MXPA03003576A (es) 2000-11-27 2001-11-27 Procedimiento para plegar polipeptidos sintetizados quimicamente.

Country Status (22)

Country Link
US (2) US20020082384A1 (es)
EP (2) EP1337549B1 (es)
JP (1) JP2004516300A (es)
KR (1) KR20030081315A (es)
CN (2) CN1249078C (es)
AT (1) ATE322501T1 (es)
AU (2) AU2960302A (es)
BR (1) BR0113091A (es)
CA (1) CA2416054A1 (es)
CU (1) CU23034A3 (es)
DE (1) DE60118598T2 (es)
DK (1) DK1337549T3 (es)
ES (1) ES2261509T4 (es)
HU (1) HUP0302395A3 (es)
IL (1) IL155506A0 (es)
MX (1) MXPA03003576A (es)
NO (1) NO20032356D0 (es)
NZ (1) NZ523679A (es)
PL (1) PL364932A1 (es)
RU (1) RU2275377C2 (es)
WO (1) WO2002050099A2 (es)
ZA (1) ZA200300642B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091310B2 (en) * 2002-09-13 2006-08-15 Chemokine Therapeutics Corporation Chemokine analogs for the treatment of human disease
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
WO2004099231A2 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
KR20070083815A (ko) * 2004-10-26 2007-08-24 론자 아게 고체상 합성에서 ｓ-알킬-술페닐 보호기
EP1814573B1 (en) 2004-10-29 2016-03-09 ratiopharm GmbH Remodeling and glycopegylation of fibroblast growth factor (fgf)
ES2449195T3 (es) 2005-01-10 2014-03-18 Ratiopharm Gmbh Factor estimulante de colonias de granulocitos glicopegilado
EP1871795A4 (en) 2005-04-08 2010-03-31 Biogenerix Ag COMPOSITIONS AND METHOD FOR PRODUCING GLYCOSYLATION MUTANTS OF A PROTEASE-RESISTANT HUMAN GROWTH HORMONE
ES2553160T3 (es) * 2005-06-17 2015-12-04 Novo Nordisk Health Care Ag Reducción y derivatización selectivas de proteínas Factor VII transformadas por ingeniería que comprenden al menos una cisteína no nativa
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
US20090081145A1 (en) * 2005-12-23 2009-03-26 Aplagen Gmbh Process for forming disulphide bridges
AU2007248855A1 (en) * 2006-05-03 2007-11-15 Mallinckrodt Inc. Composition and method for the release of protected peptides from a resin
CN101516388B (zh) 2006-07-21 2012-10-31 诺和诺德公司 通过o-联糖基化序列的肽的糖基化
WO2008057683A2 (en) 2006-10-03 2008-05-15 Novo Nordisk A/S Methods for the purification of polypeptide conjugates
EP2125863A1 (de) * 2006-12-23 2009-12-02 AplaGen GmbH Verfahren zur ausbildung von disulfidbrücken
KR20100016160A (ko) 2007-04-03 2010-02-12 바이오제너릭스 에이지 글리코페길화 ｇ―ｃｓｆ를 이용하는 치료 방법
WO2008154639A2 (en) 2007-06-12 2008-12-18 Neose Technologies, Inc. Improved process for the production of nucleotide sugars
ES2476690T3 (es) 2008-02-27 2014-07-15 Novo Nordisk A/S Moléculas conjugadas del Factor VIII
CN104844693B (zh) * 2015-06-10 2018-08-03 成都圣诺生物科技股份有限公司 一种合成利那洛肽的方法
WO2019149918A1 (en) 2018-02-02 2019-08-08 Novo Nordisk A/S Drug injection device with deflectable transducer
CN111100188A (zh) * 2018-10-25 2020-05-05 成都医学院 一种制备蜘蛛抗菌肽的方法
CN109593119A (zh) * 2019-01-27 2019-04-09 上海丽珠制药有限公司 一种[2-d-组氨酸]-醋酸亮丙瑞林的制备方法
JP7453745B2 (ja) * 2019-03-28 2024-03-21 株式会社ヤクルト本社 毒性タンパク質の活性を阻害するペプチドのスクリーニング方法及び毒性タンパク質の製造方法
CN110845595A (zh) * 2019-11-14 2020-02-28 连云港职业技术学院 一种固相合成5-tmara标记的铁调素-25的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
DE3236849A1 (de) * 1982-10-05 1984-04-05 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue thiohydrazin-1,2-dicarbonsaeure-derivate, verfahren zu ihrer herstellung und ihre verwendung
IL96682A0 (en) * 1989-12-15 1991-09-16 Amgen Inc Production of biologically active platelet-derived growth factor from high expression host cell systems
CA2072249C (en) * 1991-06-28 2003-06-17 Saiko Hosokawa Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
EP0628573A1 (en) * 1993-05-24 1994-12-14 Kao Corporation Process for producing solubilized protein
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
DE4431317A1 (de) * 1994-09-02 1996-03-07 Biotechnolog Forschung Gmbh Schutz- bzw. Ankergruppen und deren Verwendung

Also Published As

Publication number Publication date
JP2004516300A (ja) 2004-06-03
WO2002050099A2 (en) 2002-06-27
RU2275377C2 (ru) 2006-04-27
AU2002229603B2 (en) 2007-11-08
US20050239162A1 (en) 2005-10-27
EP1337549B1 (en) 2006-04-05
IL155506A0 (en) 2003-11-23
WO2002050099A3 (en) 2002-09-19
US20020082384A1 (en) 2002-06-27
DE60118598T2 (de) 2007-02-15
HUP0302395A3 (en) 2007-05-02
CN1830999A (zh) 2006-09-13
PL364932A1 (en) 2004-12-27
ES2261509T4 (es) 2008-02-16
ATE322501T1 (de) 2006-04-15
AU2960302A (en) 2002-07-01
NZ523679A (en) 2005-10-28
CA2416054A1 (en) 2002-06-27
CN1449406A (zh) 2003-10-15
EP1679318A1 (en) 2006-07-12
KR20030081315A (ko) 2003-10-17
CU23034A3 (es) 2005-03-22
DE60118598D1 (de) 2006-05-18
ES2261509T3 (es) 2006-11-16
NO20032356L (no) 2003-05-26
BR0113091A (pt) 2003-07-08
ZA200300642B (en) 2004-07-16
CN1249078C (zh) 2006-04-05
HUP0302395A2 (hu) 2003-10-28
NO20032356D0 (no) 2003-05-26
DK1337549T3 (da) 2006-07-31
EP1337549A2 (en) 2003-08-27

Similar Documents

Publication Publication Date Title
AU2960302A (en) Process for folding chemically synthesized polypeptides
ATE293159T1 (de) Stabilisierendes verdünnungsmittel für polypeptide und antigene
ATE393576T1 (en) Use of acid-stable subtilisin proteases in animal feed
LU91342I9 (es)
IL161016A (en) Polypeptides capable of ang-2 binding
PT1326630E (pt) Utilização de péptidos glp-2
DE50103437D1 (de) Künstliches Fingergelenk
IL138608A0 (en) Antibody variants and fragments thereof
AU2002217505A1 (en) Process for producing recombinant protein and fused protein
MXPA03010684A (es) Peptidos y el uso de los mismos para oscurecer la piel.
EP1384778A4 (en) PROTEIN SYNTHESIS METHOD USING ACELLULAR PROTEIN SYNTHESIS SYSTEM
CA2058934A1 (en) Processes for the recovery of microbially produced chymosin
GB0022995D0 (en) Polynucleotide
MXPA04002103A (es) Una proteina de union a caspasa-8, su preparacion y uso.
EP1375502A4 (en) PROCESS FOR PRODUCING 2,6-DIHALOGENOPURIN
DE3852105D1 (de) Verfahren zur herstellung von aprotinin und aprotinin-homologen in hefe.
AU2001256315A1 (en) Use of guanylate cyclase-c (gc-c) agonists as insulinotropic factors for treating diabetes type 2
GB0315182D0 (en) Cytokine variant polypeptides
DE69736325D1 (de) Cr1 fragmente und deren verwendung
EP1385979A4 (en) METHOD FOR IMPROVING THE TRANSLATION AND EXPRESSION OF RECOMBINANT PROTEINS
EP1331269A4 (en) NEW PROTEIN, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF
ES1043476U (es) Chapa perfeccinada
MXPA04004303A (es) Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos pai-1.
ES1054532U (es) Dispositivo para endulzar y al mismo tiempo remover una bebida.
ES1029125U (es) Bolsa para evacuaciones.

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights